IFIH1 (encoding MDA5) mutations reportedly result in aberrant type I IFN expression, leading to AGS (Aicardi–Goutières syndrome), an inflammatory disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, and chilblain skin lesions (12). This evidence concerns the gene IFIH1 and Cerebral atrophy.